Bal Pharma Ltd (BALPHARMA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524824 | NSE: BALPHARMA | Pharmaceuticals & Drugs | Small Cap

Bal Pharma Share Price

73.96 -0.61 -0.82%
as on 05-Dec'25 12:16

Bal Pharma Ltd (BALPHARMA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524824 | NSE: BALPHARMA | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Bal Pharma

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Bal Pharma stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
15.09
Market Cap:
118.8 Cr.
52-wk low:
73.6
52-wk high:
131.5

Is Bal Pharma Ltd an attractive stock to invest in?

1. Is Bal Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bal Pharma Ltd is a below average quality company.

2. Is Bal Pharma Ltd undervalued or overvalued?

The key valuation ratios of Bal Pharma Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Bal Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bal Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bal Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bal Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.1%12.8%11.8%10%2.1%12.6%12.3%10.4%10.7%9.7%-
Value Creation
Index
-0.3-0.1-0.2-0.3-0.9-0.1-0.1-0.3-0.2-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 198226208223171249280303339303294
Sales YoY Gr.-14.3%-8.1%7.4%-23.5%46.1%12.5%8.1%11.7%-10.7%-
Adj EPS 1.72.33.54.6-6.674.44.55.34.84.9
YoY Gr.-41.8%51.3%29.7%-243.6%NA-37.1%1.1%18.2%-9.3%-
BVPS (₹) 42.5475154.246.552.957.760.358.362.162.8
Adj Net
Profit
2.13.356.5-9.310.46.578.37.68
Cash Flow from Ops. 1.36.412.611.621.710.230.65.428.520.3-
Debt/CF from Ops. 54.611.77.29.14.610.23.223.34.77.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 4.8%12.1%2.6%-10.7%
Adj EPS 12.5%NA2.7%-9.3%
BVPS4.3%5.9%2.5%6.4%
Share Price -6.4% 6.2% -6.2% -39.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.85.47.28.7-13.114.37.87.68.87.97.9
Op. Profit
Mgn %
8.78.9119.24.211.48.49.27.4109.4
Net Profit
Mgn %
1.11.52.42.9-5.54.22.32.32.52.52.7
Debt to
Equity
1.31.11.31.41.51.31.21.31.51.50.3
Working Cap
Days
211221290303386270273296270290156
Cash Conv.
Cycle
71781121291791069610210112727

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 7.90%

Sales growth has been subdued in last 3 years 2.56%

Net Profit has been subdued in last 3 years 2.73%

Debt to equity has increased versus last 3 years average to 1.46

Sales growth is not so good in last 4 quarters at -8.90%

Latest Financials - Bal Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 4.9 4.3
TTM Sales (₹ Cr.) 294 295
BVPS (₹.) 62.8 49.2
Reserves (₹ Cr.) 84 62
P/BV 1.19 1.52
PE 15.09 17.40
From the Market
52 Week Low / High (₹) 73.61 / 131.45
All Time Low / High (₹) 1.60 / 167.90
Market Cap (₹ Cr.) 119
Equity (₹ Cr.) 15.9
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Bal Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Bal Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Bal Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales198226208223171249280303339302
Operating Expenses 181206185203164223257277315272
Manufacturing Costs24272427212432413834
Material Costs941048810476140153156176143
Employee Cost 36415048494044526062
Other Costs 27332324181928284233
Operating Profit 1720232072723262430
Operating Profit Margin (%) 8.7%8.9%11.0%9.2%4.1%10.6%8.4%8.7%7.1%10.0%
Other Income 13234362102
Interest 68913131211131517
Depreciation 767677771010
Exceptional Items 0000000000
Profit Before Tax 5984-91012996
Tax 233-2-01322-2
Profit After Tax 3567-999688
PAT Margin (%) 1.4%2.4%2.9%3.0%-5.2%3.6%3.1%2.0%2.3%2.6%
Adjusted EPS (₹)2.23.84.24.8-6.36.15.83.94.94.9
Dividend Payout Ratio (%)46%27%24%21%0%16%17%26%25%25%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 55677277667885959299
Share Capital 13141414141515161616
Reserves 42525863526471797683
Minority Interest0000000000
Debt66708497949992117126133
Long Term Debt16183529232427313631
Short Term Debt505249687175658790102
Trade Payables47545047394972917882
Others Liabilities 26294536403640453837
Total Liabilities 193219251257239262290348334350

Fixed Assets

Gross Block106667176828692107140157
Accumulated Depreciation5061319263339446170
Net Fixed Assets 56605857565353637987
CWIP 4200001003
Investments 1077788895
Inventories425466706860749888103
Trade Receivables576164665269789510295
Cash Equivalents 45443457138
Others Assets 29375153536770764350
Total Assets 193219251257239262290348334350

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 16131222103152920
PBT 5984-91012996
Adjustment 11151516171714192225
Changes in Working Capital -14-16-10-614-176-222-8
Tax Paid -1-1-1-2-0-0-1-1-5-2
Cash Flow From Investing Activity -14-8-16-12-3-7-13-22-19-15
Capex -14-8-4-5-4-3-8-15-11-19
Net Investments 000-20-1-1-1-93
Others 00-12-50-3-5-711
Cash Flow From Financing Activity 12240-20-3-1717-7-8
Net Proceeds from Shares 0000030411
Net Proceeds from Borrowing 10017-5-90346-5
Interest Paid -6-8-9-12-12-12-10-12-14-17
Dividend Paid -2-2-2-1-10-1-2-2-2
Others 1012-31935-823215
Net Cash Flow -001-0-10-003-2

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)5.188.768.569.07-12.4712.6110.476.88.278.17
ROCE (%)10.0712.7711.769.952.0912.5712.2810.410.79.69
Asset Turnover Ratio1.131.130.890.880.6911.020.950.990.88
PAT to CFO Conversion(x)0.331.22.171.71N/A1.113.440.833.632.5
Working Capital Days
Receivable Days92931091061258996104106119
Inventory Days70761051111479387103100115
Payable Days166176215171209114144191175204

Bal Pharma Ltd Stock News

Bal Pharma Ltd FAQs

The current trading price of Bal Pharma on 05-Dec-2025 12:16 is ₹73.96.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Bal Pharma stood at ₹118.8.
The latest P/E ratio of Bal Pharma as of 04-Dec-2025 is 15.09.
The latest P/B ratio of Bal Pharma as of 04-Dec-2025 is 1.19.
The 52-week high of Bal Pharma is ₹131.4 and the 52-week low is ₹73.61.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bal Pharma is ₹294.1 ( Cr.) .

About Bal Pharma Ltd

Bal Pharma Limited is a leading Indian Pharmaceutical Company with 25+ years of experience, specialized in Prescription Drugs, Generic & OTC Products, Intravenous Infusion and Bulk Actives.

The company strives hard to improve the quality of life for patients by providing them products that are Safe, Effective, High Quality and Affordable.

The company’s API and FDF are produced at world class manufacturing facilities. APIs are largely exported to Europe, Far East, Latin America, Africa, Middle East and other World markets. The FDF are exported to Semi-Regulated, Non-Regulated market and are now foraying to regulated market. The company is also one of the strong contenders for World Tender Business.

Business area of the company

The company is engaged in the manufacturing and selling of pharmaceutical products. The company caters to both domestic and international markets.

Business segments

API Intermediate: The company’s API (Active Pharmaceutical Ingredients) business began in 1996 with a simple objective of facilitating the manufacture of niche molecules that have been able to take the benefits of vertical integration to international and domestic markets. Bal Pharma’s API business has the competence and knowledge to undertake more than 30 different types of complex chemical reactions.

Finished formulations: Bal Pharma has a winning formula of cutting edge technology, handled by a highly qualified professional with a passion to deliver beyond excellence. The company is successfully exporting Finished Formulation to many countries. The company offers extensive range of products covering dosage forms - tablets, capsules, syrups, suspensions, IV infusions, Ophthalmic, creams and ointments to various Semi-Regulated markets.

Ayurveda/Herbal: Ayurveda is India’s traditional, natural system of medicine that has been practiced for more than 5,000 years. Ayurveda is a Sanskrit word that, when literally translated, means 'science of life' or 'practices of longevity.' Ayurveda provides an integrated approach to preventing and treating illness through lifestyle interventions and natural therapies. The company’s objective of providing “Good life to All” launched its Ayurvedic Division - Bal Vedics in 2003. Bal Vedics is dedicated to bringing out ‘nature’s best’ through International Quality Natural Formulations that combine traditional Indian Wisdom of medicine with Scientific Manufacturing.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×